Pichette and colleagues focused on the role of H2S in glucagon-like peptide-1 (GLP-1) expression, a hormone involved in glucose homeostasis and considered a therapeutical target for T2D and obesity treatment. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.